Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About Molecular Pharmacology
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About Molecular Pharmacology
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Contribution of Disruption of the Nuclear Factor-κB Pathway to Induction of Apoptosis in Human Leukemia Cells by Histone Deacetylase Inhibitors and Flavopiridol

Ning Gao, Yun Dai, Mohamed Rahmani, Paul Dent and Steven Grant
Molecular Pharmacology October 2004, 66 (4) 956-963; DOI: https://doi.org/10.1124/mol.104.002014
Ning Gao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun Dai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Rahmani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Dent
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Grant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  •     Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Flavopiridol markedly inhibits activation of NF-κB induced by histone deacetylase inhibitors in human leukemia cells. A, U937 cells were untreated or treated with 1 mM NaB, 100 nM FP, or the combination (FP + NaB) for 24 h, after which nuclear extracts were then prepared and subjected to EMSA as described under Materials and Methods. For C + C′, a 100-fold excess of unlabeled NF-κB oligonucleotides was added to the nuclear extract obtained from untreated cells before the addition of labeled NF-κB oligonucleotides. B, U937 cells were untreated or treated with 1.5 μM SAHA, 100 nM FP, or the combination of FP and SAHA for 24 h. NF-κB DNA binding activity was determined by EMSA as described above. C, for the supershift assay, nuclear extracts were preincubated with specific anti-p50 and anti-p65 antibodies and subjected to EMSA. Results are representative of three separate studies. For all studies, lanes were loaded with 4 μgof protein. NF-κB DNA binding signals were quantified using Scion Image software (Scion Corporation). Bottom, Mean densitometric values from three independent experiments were normalized to controls that were assigned an arbitrary value of 1.0. The data represent the means ± S.D. (n = 3). OD, optical density; NS, nonspecific; C, control.

  •     Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Inhibition of NF-κB activity in U937 cells transfected with an IκBα super-repressor mutant. U937 cells were stably transfected with an IκBα mutant (Ser32, 36/Ala) or an empty vector [pcDNA (3.1)] as described under Materials and Methods. Two U937 cell clones stably expressing IκBα mutants (designated 2C8 and 2H6) were then isolated and prepared. A, empty vector control cells and the two IκBα mutant transfectants (2C8 and 2H6) were treated with 1 mM NaB, 100 nM FP, or the combination of FP and NaB, after which the nuclear extracts were prepared and subjected to EMSA as described under Materials and Methods. B, empty vector controls and the two IκBα mutant transfectants (2C8 and 2H6) were treated with 1.5 μM SAHA, 100 nM FP, or the combination of FP and SAHA, after which nuclear extracts were prepared and subjected to EMSA analysis as described above. Bottom, densitometric analysis of signals from EMSA analysis shown above. Results represent values compared with vector controls and are representative of three separate studies. NF-κB DNA binding signals were quantified and analyzed as described in Fig. 1. The data are expressed as means ± S.D. (n = 3).

  •     Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Stable transfection of cells with an IκBα mutant enhances FP/NaB- and FP/SAHA-induced apoptosis in U937 cells. U937 cells were stably transfected with IκBα mutant (Ser32, 36/Ala) or an empty vector (pcDNA3.1) as described under Materials and Methods. U937/IκBα mutant (clones 2C8 and 2H6) and /pcDNA3.1 cells were treated with 100 nM FP, the histone deacetylase inhibitors NaB (1 mM) or SAHA (1.5 μM), or the combination of FP/NaB (A) and FP/SAHA (B) for 24 h. Cells were stained with Annexin V/PI, and apoptosis was determined using flow cytometry as described under Materials and Methods. The values obtained from the Annexin V assay represent the means ± S.D. for three separate experiments. ⋆⋆, values for U937/IκBα mutant cells (clones 2C8 and 2H6) significantly greater than those for empty vector controls (pcDNA3.1 cells) by the Student's t test; p < 0.01. ⋆⋆⋆, p < 0.001.

  •     Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Stable transfection of cells with an IκBα enhances FP/NaB- and FP/SAHA-induced mitochondrial injury in U937 cells. U937/IκBα mutant (clones 2C8 and 2H6) and /pcDNA3.1 cells were treated with 100 nM FP, NaB (1 mM) or SAHA (1.5 μM), or the combination of FP/NaB (A) and FP/SAHA (B) for 24 h. The cytosolic S-100 fractions were prepared and subjected to Western blot assay using antibodies against cytochrome c (cyto c) and AIF. Each lane was loaded with 20 μg of protein; blots were subsequently stripped and reprobed with antibodies directed against β-actin to ensure equivalent loading and transfer. Two additional studies yielded equivalent results.

  •     Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Stable transfection of cells with an IκBα enhances FP/NaB- and FP/SAHA-induced caspase activation in U937 cells. U937/IκBα mutant (clones 2C8 and 2H6) and /pcDNA3.1 cells were treated with 100 nM FP, NaB (1 mM) or SAHA (1.5 μM), or the combination of FP/NaB (A) and FP/SAHA (B) for 24 h. Total cellular extracts were prepared and subjected to Western blot assay using antibodies against PARP, C-caspase-3, caspase-8, caspase-9, and β-actin as indicated. Each lane was loaded with 20 μg of protein; blots were subsequently stripped and reprobed with antibodies directed against β-actin to ensure equivalent loading and transfer. Two additional studies yielded equivalent results. C-caspase-3, cleaved caspase 3; CF, cleavage fragment.

  •     Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Stable transfection of RelA/p65 siRNA enhances FP/NaB- and FP/SAHA-induced apoptosis in U937 cells. U937 cells were stably transfected with RelA/p65 siRNA or an empty vector (3.1-H1 hygro) as described under Materials and Methods. A, comparison of the expression of RelA/p65 in U937/p65 siRNA and U937/3.1-H1 hygro cells is shown by Western blot. U937/p65 siRNA (p65) and /3.1-H1 hygro (3.1) cells were treated with FP (100 nM), NaB (1 mM), or SAHA (1.5 μM), or the combination of FP/NaB (B) and FP/SAHA (C) for 24 h. Cells were stained with Annexin V/PI, and apoptosis was determined using flow cytometry. The values obtained from Annexin V assays represent the means ± S.D. for three separate experiments. ⋆⋆, values for RelA/p65 siRNA cells significantly greater than those for empty vector controls (3.1) by the Student's t test, p < 0.01.

  •     Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Stable transfection with an IκBα mutant enhances FP/NaB and FP/SAHA-induced activation of phosphor-JNK (P-JNK) and down-regulation of XIAP, p21CIP1/WAF1, and Mcl-1. A, U937/IκBα mutant (2C8 and 2H6) and /pcDNA3.1 cells were treated with 1 mM NaB, 100 nM FP, or the combination of FP/NaB. B, transfected cells were also treated with 1.5 μM SAHA, 100 nM FP, or the combination of FP/SAHA. Total cellular extracts were prepared and subjected to Western blot assay using antibodies against phosphor-JNK, JNK, XIAP, Mcl-1, p21CIP1/WAF1, p27KIP1, and β-actin. Each lane was loaded with 20 μg of protein; blots were subsequently stripped and reprobed with antibodies to actin to ensure equivalent loading and transfer. Two additional studies yielded equivalent results.

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 66 (4)
Molecular Pharmacology
Vol. 66, Issue 4
1 Oct 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of Disruption of the Nuclear Factor-κB Pathway to Induction of Apoptosis in Human Leukemia Cells by Histone Deacetylase Inhibitors and Flavopiridol
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
Citation Tools
Research ArticleArticle

Contribution of Disruption of the Nuclear Factor-κB Pathway to Induction of Apoptosis in Human Leukemia Cells by Histone Deacetylase Inhibitors and Flavopiridol

Ning Gao, Yun Dai, Mohamed Rahmani, Paul Dent and Steven Grant
Molecular Pharmacology October 1, 2004, 66 (4) 956-963; DOI: https://doi.org/10.1124/mol.104.002014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Contribution of Disruption of the Nuclear Factor-κB Pathway to Induction of Apoptosis in Human Leukemia Cells by Histone Deacetylase Inhibitors and Flavopiridol

Ning Gao, Yun Dai, Mohamed Rahmani, Paul Dent and Steven Grant
Molecular Pharmacology October 1, 2004, 66 (4) 956-963; DOI: https://doi.org/10.1124/mol.104.002014
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Restoration of physiological expression of 5-HT6 into the primary cilia of null mutant neurons lengthens both primary cilia and dendrites.
  • Insulin receptor plasma membrane levels increased by the progesterone receptor membrane component 1
  • Efficient high-throughput screening by ER Ca2+ measurement to identify inhibitors of ryanodine receptor Ca2+-release channels
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2018 by the American Society for Pharmacology and Experimental Therapeutics